Simultaneous VENTANA IHC and RT-PCR testing of ALK status in Chinese non-small cell lung cancer patients and response to crizotinib. [electronic resource]
Producer: 20190619Description: 93 p. digitalISSN:- 1479-5876
- Adult
- Aged
- Aged, 80 and over
- Anaplastic Lymphoma Kinase -- genetics
- Asian People
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Crizotinib -- pharmacology
- Female
- High-Throughput Nucleotide Sequencing
- Humans
- Immunohistochemistry
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Progression-Free Survival
- Reverse Transcriptase Polymerase Chain Reaction -- methods
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.